ICU MEDICAL INC/DE
For the period ended Jun 30, 2025. Filed Aug 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 7, 2025
ICUI$182.11+1.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets at and
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except par value data and treasury shares)
| June 30,2025 · December 31,2024 | |||
|---|---|---|---|
| (Unaudited) | (1) | ||
| ASSETS | |||
| CURRENT ASSETS: | |||
| Cash and cash equivalents | $300,025 | $308,566 | |
| Accounts receivable, net of allowance for doubtful accounts $13,541 at June 30, 2025 and $12,977 at December 31, 2024 | 179,495 | 182,828 | |
| Inventories | 616,474 | 584,676 | |
| Prepaid expenses and other current assets | 84,121 | 81,531 | |
| Assets held for sale | — | 284,382 | |
| TOTAL CURRENT ASSETS | 1,180,115 | 1,441,983 | |
| PROPERTY, PLANT AND EQUIPMENT, net | 452,442 | 442,746 | |
| OPERATING LEASE RIGHT-OF-USE ASSETS | 58,888 | 53,295 | |
| GOODWILL | 1,501,920 | 1,432,772 | |
| INTANGIBLE ASSETS, net | 698,009 | 740,789 | |
| DEFERRED INCOME TAXES | 23,068 | 24,211 | |
| OTHER ASSETS | 61,322 | 65,097 | |
| INVESTMENTS IN UNCONSOLIDATED AFFILIATES | 131,625 | 3,038 | |
| TOTAL ASSETS | $4,107,389 | $4,203,931 | |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||
| CURRENT LIABILITIES: | |||
| Accounts payable | $168,820 | $148,020 | |
| Accrued liabilities | 313,798 | 306,923 | |
| Current portion of long-term debt | — | 51,000 | |
| Income tax payable | 159 | 17,328 | |
| Liabilities held for sale | — | 32,911 | |
| TOTAL CURRENT LIABILITIES | 482,777 | 556,182 | |
| LONG-TERM DEBT | 1,337,731 | 1,531,858 | |
| OTHER LONG-TERM LIABILITIES | 96,289 | 66,745 | |
| DEFERRED INCOME TAXES | 43,220 | 48,814 | |
| INCOME TAX LIABILITY | 31,596 | 35,097 | |
| COMMITMENTS AND CONTINGENCIES (Note 20) | |||
| STOCKHOLDERS’ EQUITY: | |||
| Convertible preferred stock, $1.00 par value; Authorized — 500 shares; Issued and outstanding — none | — | — | |
| Common stock, $0.10 par value; Authorized — 80,000 shares; Issued — 24,686 shares at June 30, 2025 and 24,518 shares at December 31, 2024; and outstanding — 24,685 shares at June 30, 2025 and 24,517 shares at December 31, 2024 | 2,469 | 2,452 | |
| Additional paid-in capital | 1,435,935 | 1,412,118 | |
| Treasury stock, at cost (43 shares at June 30, 2025 and 571 shares at December 31, 2024) | (6) | (92) | |
| Retained earnings | 710,020 | 690,158 | |
| Accumulated other comprehensive loss | (32,642) | (139,401) | |
| TOTAL STOCKHOLDERS' EQUITY | 2,115,776 | 1,965,235 | |
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $4,107,389 | $4,203,931 | |
(1)December 31, 2024 balances were derived from audited consolidated financial statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.